Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer
Simonetta M. Leto(Candiolo Cancer Institute), Andrea Bertotti(Torino e-district)
Cited by 44
Related Papers
A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
|Cancer Discovery|2011|948
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
|Nature Communications|2017|322
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients
|Nature Communications|2024|13
XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncology
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3